Stories of Hope & Healing
Real patients sharing their journey of recovery and the compassionate care they received throughout their treatment. Every story represents a life transformed and a family given hope.
Treatment Outcomes by Numbers
Comprehensive statistical analysis of patient outcomes across different cancer types and treatment methodologies.
5-Year Survival Rates by Cancer Type
Treatment Response Rates
Lung Cancer: Targeted therapy (EGFR, ALK, ROS1, etc.)
Patient Success Stories
Real stories from real patients who have overcome cancer with personalized treatment approaches and compassionate care.
Mrs Z, 55
Treatment SuccessTracheal SCC • III • Diagnosed June 2025
Treatment Approach
Tracheal Squamous Cell Carcinoma invading Esophagus presented with severe respiratory distress and difficulty in deglutation. Figures 1,2 pretreatment. After CRT it showed complete Response with no symptoms. Figures 3,4 post treatment.
Patient Experience
"NA"
Mrs X, 64
Treatment SuccessmHCC • IV • Diagnosed Nov 2024
Treatment Approach
Started immunotherapy with Atezolizumab + Bevacizumab C6 completed April 2025> Complete Radiological Response denovo mHCC treated with IMbrave150 trial with Pal RT to bony lesions. Notably, ~5.5% of patients achieved complete responses on atezo/bev.
Patient Experience
"NA"
Mrs FI, 55
Treatment SuccessmOvarian Carcinoma • IV • Diagnosed Dec 2018
Treatment Approach
Surgery: 18.12.2018, Total Hysterectomy with right salpingo-oophorectomy with left ovarian mass, pelvic peritoneum, B/L diaphragmatic peritoneum, sigmoid deposit and omentum @India Chemotherapy: 3 cycle of NACT with Paclitaxel and Carboplatin from 05.10.2018 up to 16.11.2018 @Tata> Underwent Surgery on 18.12.2018 > ADCT 3 cycle completed on 14.02.2019- All outside Due to recc and mets > Started 2nd line chemo with Docetaxel + Carboplatin, Cycle 3 up to 13/08/20> From C4 Inj Avastin added & Cycle 6 is completed on 15.10.2020 > Maintenance 13 Bevacizumab is completed on 18.07.21 Started 3rd line chemotherapy with Gem-Carbo-Beva C1 from 23.05.22. Cycle 6 Day 8 is completed on 26.09.22; Maintenance Bevacizumab has been started from 17.10.22 > Maintenance 40 with Bevacizumab is due on 06.04.25 Started Olaparib since 20.03.23 > STOPED from Sep 2025
Patient Experience
"NA"
Mr Y, 72
Treatment SuccessmCarcinoma Lung (SCLC) • IV • Diagnosed Aug 2023
Treatment Approach
SCLC of Left Lung with de novo bone metastasis- Dx Jan 2022 (Post RT to S1-S2)> Post Palliative RT to bone> Post CT (Carboplatin-Etoposide) & Immunotherapy (Atezolizumab x 23 cycles total) up to July 2023> New Oligo Brain Metastasis Aug 2023 treated with SRT 27Gy in 3 Fraction> Follow up on July 2025- still in remission.
Patient Experience
"NA"
Showing 1 to 4 of 5 success stories
Treatment Approaches & Methodologies
Comprehensive overview of treatment methodologies used to achieve exceptional patient outcomes across various cancer types.
Our Multidisciplinary (MDT) Approach
||Why a Team Approach?|| Cancer is complex. No single doctor can cover every aspect of diagnosis and treatment. That’s why we use a Multidisciplinary Team (MDT) approach – bringing together different specialists to design the best plan for you. ||Who is in Your MDT?|| 1. Cancer Specialists (Medical, Surgical, Radiation Oncologists) – decide the best mix of surgery, chemotherapy, targeted therapy, immunotherapy, or radiotherapy. 2. Radiologists – review scans (CT, MRI, PET-CT) to understand the full picture. 3. Pathologists – study biopsy samples to confirm the exact cancer type and biology. 4. Nurses & Support Staff – guide you through treatment, side-effect care, and emotional support. 5. Other Experts (as needed) – depending on the cancer type (lung, breast, GI, gynecological, etc.). ||How We Care for You|| 1. Diagnosis & Staging: Tests (biopsy, imaging) confirm the type of cancer and whether it is localized (limited) or metastatic (spread). 2. MDT Discussion: Your case is presented at the tumor board. All specialists review your results and decide on a personalized treatment plan. 3. Treatment Plan a. Localized Cancer: Often treated with surgery and/or radiotherapy, plus medicines (chemotherapy, hormonal, or targeted therapy) to reduce risk of recurrence. b. Metastatic Cancer: Treatment focuses on controlling the disease, extending survival, and maintaining quality of life with systemic therapies and supportive care. 4. Treatment Implementation: You receive treatment in a step-by-step, coordinated manner. Each step is monitored and adjusted if needed. ||Follow-up & Survivorship|| After treatment, regular visits, scans, and counseling ensure early detection of recurrence, management of side effects, and long-term well-being. ||The Benefit to You|| 1. One team, many experts working for you 2. Personalized care – no two patients get the same plan 3. Evidence-based decisions backed by the latest guidelines 4. Better survival & quality of life compared to single-specialist treatment
Breast Cancer- Early Detection & Our Multidisciplinary Approach
||Erly Detection Saves Lives|| *Breast cancer outcomes improve significantly when the disease is detected at an early stage. At our center, we encourage: 1. Self-awareness – Regular breast self-examination helps identify unusual lumps or changes. 2. Screening – Mammogram, ultrasound, and, when needed, MRI for high-risk women allow detection before symptoms appear. 3. Prompt Evaluation – Any suspicious finding is quickly assessed by imaging and biopsy to ensure an accurate diagnosis. ||Why a Multidisciplinary Team (MDT) Matters|| Breast cancer treatment is not one-size-fits-all. Every patient’s case is discussed in our multidisciplinary tumor board, which includes: 1. Radiologists – To interpret imaging and define the extent of disease. 2. Pathologists – To confirm the exact tumor type and molecular profile. 3. Breast Surgeons – To plan surgery with the best oncologic and cosmetic outcome. 4. Medical Oncologists – To advise on chemotherapy, targeted therapy, or immunotherapy. 5. Radiation Oncologists – To design safe and effective radiotherapy plans. Together, this team reviews your case and decides on the most effective, personalized treatment plan. ||Our Treatment Pathway|| 1. Diagnosis & Staging – Imaging (mammogram, USG, MRI, PET-CT) and biopsy confirm the cancer and stage. 2. MDT Discussion – Experts meet to analyze findings and recommend the best course of treatment. 3. Individualized Treatment – This may include surgery, chemotherapy, radiotherapy, targeted therapy, hormonal therapy, or a combination. 3. Follow-Up & Support – Long-term monitoring, survivorship care, and counseling ensure ongoing health and quality of life. ||Patient Benefit|| 1. One-stop coordinated care 2. Evidence-based decisions 3. Higher accuracy in diagnosis and staging 4. Treatment tailored for best survival and quality of life
Quality of Life Improvements
Measuring success beyond survival rates - tracking patient wellbeing, functionality, and life satisfaction throughout and after treatment.
Quality of Life Scores (0-10 Scale)
Long-term Follow-up Results
Important Medical Disclaimer
The patient outcomes and success stories presented on this page are based on actual treatment results but have been anonymized to protect patient privacy. Individual results may vary significantly based on numerous factors including cancer type, stage, patient health status, genetic factors, and response to treatment.
These outcomes should not be considered as guarantees of treatment success or as medical advice. Every cancer case is unique, and treatment decisions should always be made in consultation with qualified oncology professionals based on individual circumstances.
Statistical data presented reflects outcomes from our patient population and may not be representative of broader population outcomes. All treatment approaches mentioned require thorough evaluation and may not be suitable for every patient.
Ready to Begin Your Journey to Recovery?
Every success story starts with a single step. Schedule your consultation today to discuss your personalized treatment options and begin your path to healing.